Mark A. Attarian
No más puestos en curso
Perfil
Mark A.
Attarian served as Chief Financial Officer at Track Group, Inc. in 2016.
Prior to that, he was the Chief Financial Officer & Interim EVP at Molecular Insight Pharmaceuticals, Inc. and the Chief Financial Officer & Treasurer at Joslin Diabetes Center, Inc. Attarian received his undergraduate degree from St. Lawrence University.
Antiguos cargos conocidos de Mark A. Attarian.
Empresas | Cargo | Fin |
---|---|---|
TRACK GROUP, INC. | Director Financiero/CFO | 15/11/2016 |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Director Financiero/CFO | - |
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Director Financiero/CFO | - |
Formación de Mark A. Attarian.
St. Lawrence University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TRACK GROUP, INC. | Electronic Technology |
Empresas privadas | 2 |
---|---|
Joslin Diabetes Center, Inc.
Joslin Diabetes Center, Inc. Pharmaceuticals: MajorHealth Technology Joslin Diabetes Center, Inc. is a non-profit organization, which engages in the development of pharmaceuticals for diabetes. It provides adult care, pediatric care, eye care, and education programs and classes. The company was founded by Elliott P. Joslin in 1893 and is headquartered in Boston, MA. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
- Bolsa de valores
- Insiders
- Mark A. Attarian